Irreversible electroporation of the liver and liver hilum in swine

HPB

Volumn 13, Issue 3, 2011, Pages 168-173

  Charpentier, Kevin P ^a   Wolf, Farrah ^a   Noble, Lelia ^a   Winn, Brody ^a   Resnick, Murray ^a   Dupuy, Damian E ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

ablation; electroporation; liver; tumour

Indexed keywords

TRIPHENYLTETRAZOLIUM;

ABLATION THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; CONTROLLED STUDY; ELECTROPORATION; FEMALE; HEPATIC ARTERY; IRREVERSIBLE ELECTROPORATION; LIVER HILUS; LIVER NECROSIS; LIVER SURGERY; NONHUMAN; PORTAL VEIN; STAINING;

EID: 79951672719     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00261.x     Document Type: Article

References (26)

1. Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, et al. (2005) Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl 11: 1117-1126. (Pubitemid 41341763)
2. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, et al. (2004) Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 240: 900-909. (Pubitemid 39425785)
3. Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, et al. (2002) Small hepatocellular carcinoma: comparison of radiofrequency ablation and percutaneous microwave coagulation therapy. Radiology 223: 331-337. (Pubitemid 34454307)
4. Goldberg SN, Dupuy D,. (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities-Part I. J Vasc Interv Radiol 12: 1021-1032. (Pubitemid 32844849)
5. Goldberg SN, Hahn PF, Tanabe KK, Mueller PR, Schima W, Athanasoulis CA, et al. (1998) Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 9: 101-111. (Pubitemid 28049697)
6. Rubinsky B, Onik G, Mikus P,. (2007) Irreversible electroporation: a new ablation modality-clinical implications. Technol Cancer Res Treat 6: 37-48. (Pubitemid 46389347)
7. Lee EW, Loh CT, Kee ST,. (2007) Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 6: 287-294.
8. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, et al. (1981) Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 101: 593-600. (Pubitemid 11120523)
9. Charpentier KP, Wolf F, Resnick M, Noble L, Winn B, Dupuy D,. (2010) Irreversible electroporation of the pancreas in swine: a pilot study. HPB 12: 348-351.
10. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, et al. (2009) SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute, based on November 2008 SEER data submission, posted to the SEER web site.
11. Scheele J, Stangl R, Altendorf-Hofmann A, Paul M,. (1995) Resection of colorectal liver metastasis. World J Surg 19: 59-71.
12. Bismuth H, Adam R, Lévi F, Farabos C, Waechter F, Castaing D, et al. (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224: 509-520.
13. Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Okuno A, et al. (1999) Aggressive surgical resection for hepatic metastases involving the inferior vena cava. Am J Surg 177: 294-298. (Pubitemid 29218338)
14. Boring CC, Squire TS, Tong T, Montgomery S,. (1994) Cancer statistics. CA Cancer J Clin 44: 7-26. (Pubitemid 24035713)
15. Bosch FX, Ribes J, Cleries R, Diaz M,. (2005) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9: 191-211.
16. Di Bisceglie AM,. (2002) Epidemiology and clinical presentation of hepatocellular carcinoma. J Vasc Interv Radiol 13: S169-S171.
17. Wolf FJ, Beland MD, Grand DJ, Iannitti D, Hass RA, Charpentier KP, et al. (2009) Microwave Ablation of Hepatic Malignancies: Effectiveness and Safety in 70 Patients. Chicago, IL: Radiology Society of North America.
18. Mir LM, Orlowski S, Belehradek J, Paoletti C,. (1991) Electrochemotherapy potentiation of antitumour effects of bleomycin by local electrical pulses. Eur J Cancer 27: 68-72.
19. Panje WR, Hier MP, Garman GR, Harrell E, Goldman A, Bloch I,. (1998) Electroporation therapy of head and neck cancer. Ann Otol Rhinol Laryngol 107: 779-785.
20. Allegretti JP, Panje WR,. (2001) Electroporation therapy for head and neck cancer including carotid artery involvement. Laryngoscope 111: 52-56. (Pubitemid 32061951)
21. Rabussay DP, Nanda GS, Goldfarb PM,. (2002) Enhancing the effectiveness of drug-based cancer therapy by electroporation (electropermeabilization). Technol Cancer Res Treat 1: 71-82. (Pubitemid 36553958)
22. Bloom DC, Goldfarb PM,. (2005) The role of intratumour therapy with electroporation and bleomycin in the management of advanced Squamous cell carcinoma of the head and neck. Eur J Surg Oncol 31: 1029-1035. (Pubitemid 41671119)
23. Miller L, Leor J, Rubinsky B,. (2005) Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 4: 699-705. (Pubitemid 43083355)
24. Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, Davalos R, et al. (2007) Tumor ablation with irreversible electroporation. PLoS ONE 11: 1-8.
25. Mali B, Jarm T, Corovic S, Paulin-Kosir MS, Cemazar M, Sersa G, et al. (2008) The effect of electroporation pulses on functioning of the heart. Med Biol Eng Comput 46: 745-757.
26. Ball C, Thomson KR, Kavnoudias H,. (2010) Irreversible electroporation: a new challenge in 'out of operating theater' anesthesia. Anesth Analg 110: 1305-1309.